Bionetworking in Asia Public Lecture Series and the Centre for Global Health Policy present:
‘Regenerative medicine in Europe: Political conflicts, economic biases in regulation’
University of Sussex
Date: Wednesday 27th of February
Location: Arts A 103, University of Sussex
The life sciences and the global bioeconomy are moving ever upward in governments’ agendas, driven by visions of economic reward and a medical revolution. EU regulation moulds the international dynamics of new biomedical markets.
Alex Faulkner traces developments in EU regulation, including tissue engineering, medical devices and cell therapy, and stem cell therapy, analysing debates on the collection of human materials, assessment of products for safety and market authorisation, and patenting of biotechnologies.
Alex shows how the emergence of a ‘harmonised’ product regulation for ‘Advanced Therapy Medicinal Products’ masks conflicts between industry sectors, which exploit ambiguities in the definition of materials and ‘modes of action’. A case at the European Court of Justice further illustrates the politically malleable nature of regenerative cell technologies.
For inquiries: firstname.lastname@example.org